Masuda T, Murakami K, Sugiura K, Sakui S, et al. Safety and immunogenicity of NVX-CoV2373 (TAK-019) vaccine in healthy Japanese adults: Interim report of a phase I/II randomized controlled trial. Vaccine 2022 Apr 29. pii: S0264-410X(22)00463.
PMID: 35501178